Single User License
INR 170075
Site License
INR 340150
Corporate User License
INR 510225

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Viscosupplementation-Pipeline Review

Viscosupplementation-Pipeline Review


  Request for Sample Report

Executive Summary

Viscosupplementation-Pipeline Review, 2015

GlobalData's Medical Devices sector report, "Viscosupplementation-Pipeline Review, 2015" provides an overview of Viscosupplementation currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Viscosupplementation pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type

Scope

Extensive coverage of the Viscosupplementation under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Viscosupplementation and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Viscosupplementation under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 4

2 Introduction 5

2.1 Viscosupplementation Overview 5

3 Products under Development 6

3.1 Viscosupplementation-Pipeline Products by Stage of Development 6

3.2 Viscosupplementation-Pipeline Products by Territory 7

3.3 Viscosupplementation-Pipeline Products by Regulatory Path 8

3.4 Viscosupplementation-Pipeline Products by Estimated Approval Date 9

3.5 Viscosupplementation-Ongoing Clinical Trials 10

4 Viscosupplementation-Pipeline Products under Development by Companies 11

4.1 Viscosupplementation Companies-Pipeline Products by Stage of Development 11

4.2 Viscosupplementation-Pipeline Products by Stage of Development 12

5 Viscosupplementation Companies and Product Overview 13

5.1 Anika Therapeutics, Inc. Company Overview 13

5.1.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 13

5.2 BioPolymer GmbH & Co. KG Company Overview 17

5.2.1 BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Carbylan Therapeutics, Inc. Company Overview 19

5.3.1 Carbylan Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

5.4 Chi2Gel Ltd. Company Overview 25

5.4.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25

5.5 Cocoon Biotech, Inc. Company Overview 26

5.5.1 Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Flex Biomedical, Inc. Company Overview 27

5.6.1 Flex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.7 Moebius Medical Ltd. Company Overview 28

5.7.1 Moebius Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28

5.8 OrthogenRx Inc. Company Overview 29

5.8.1 OrthogenRx Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

5.9 Synolyne Pharma Company Overview 30

5.9.1 Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview 30

5.10 University of Kansas Company Overview 31

5.10.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 31

6 Viscosupplementation- Recent Developments 32

7 Appendix 35

7.1 Methodology 35

7.2 About GlobalData 37

7.3 Contact Us 37

7.4 Disclaimer 37

1.2 List of Figures

Figure 1: Viscosupplementation-Pipeline Products by Stage of Development 6

Figure 2: Viscosupplementation-Pipeline Products by Territory 7

Figure 3: Viscosupplementation-Pipeline Products by Regulatory Path 8

Figure 4: Viscosupplementation-Pipeline Products by Estimated Approval Date 9

Figure 5: Viscosupplementation-Ongoing Clinical Trials 10

1.1 List of Tables

Table 1: Viscosupplementation-Pipeline Products by Stage of Development 6

Table 2: Viscosupplementation-Pipeline Products by Territory 7

Table 3: Viscosupplementation-Pipeline Products by Regulatory Path 8

Table 4: Viscosupplementation-Pipeline Products by Estimated Approval Date 9

Table 5: Viscosupplementation-Ongoing Clinical Trials 10

Table 6: Viscosupplementation Companies-Pipeline Products by Stage of Development 11

Table 7: Viscosupplementation-Pipeline Products by Stage of Development 12

Table 8: Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 13

Table 9: Cingal-Product Status 13

Table 10: Cingal-Product Description 14

Table 11: Anika Therapeutics, Inc.-Ongoing Clinical Trials Overview 15

Table 12: Cingal-To Evaluate the Safety of a Repeat Injection of Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee (Cingal 13-02: An Open-label, Follow-on Study to Cingal 13-01) 16

Table 13: BioPolymer GmbH & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 17

Table 14: Crespine Gel-Product Status 17

Table 15: Crespine Gel-Product Description 17

Table 16: Crespine Gel Plus-Product Status 18

Table 17: Crespine Gel Plus-Product Description 18

Table 18: Carbylan Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 19: Hydros-Product Status 19

Table 20: Hydros-Product Description 19

Table 21: Hydros TA-Product Status 20

Table 22: Hydros TA-Product Description 20

Table 23: Hydros TA-Hip-Product Status 21

Table 24: Hydros TA-Hip-Product Description 21

Table 25: Carbylan Therapeutics, Inc.-Ongoing Clinical Trials Overview 22

Table 26: Hydros-A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated wWith Osteoarthritis in the Knee 23

Table 27: Hydros TA-A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated wWith Osteoarthritis in the Knee 24

Table 28: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 25

Table 29: Chi2Knee-Product Status 25

Table 30: Chi2Knee-Product Description 25

Table 31: Cocoon Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 32: Silk Hydrogel-Product Status 26

Table 33: Silk Hydrogel-Product Description 26

Table 34: Flex Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 35: Flex Polymer-Product Status 27

Table 36: Flex Polymer-Product Description 27

Table 37: Moebius Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28

Table 38: MM-II-Product Status 28

Table 39: MM-II-Product Description 28

Table 40: OrthogenRx Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Table 41: OrthogenRx Device-Product Status 29

Table 42: OrthogenRx Device-Product Description 29

Table 43: Synolyne Pharma Pipeline Products & Ongoing Clinical Trials Overview 30

Table 44: Arthrovisc-Product Status 30

Table 45: Arthrovisc-Product Description 30

Table 46: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 31

Table 47: 3-D Colloidal Gel-Product Status 31

Table 48: 3-D Colloidal Gel-Product Description 31

Table 49: Glossary 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Anika Therapeutics, Inc.

BioPolymer GmbH & Co. KG

Carbylan Therapeutics, Inc.

Chi2Gel Ltd.

Cocoon Biotech, Inc.

Flex Biomedical, Inc.

Moebius Medical Ltd.

OrthogenRx Inc.

Synolyne Pharma

University of Kansas

Anika Therapeutics, Inc., Cingal, BioPolymer GmbH & Co. KG, Crespine Gel, Crespine Gel Plus, Carbylan Therapeutics, Inc., Hydros, Hydros TA, Hydros TA - Hip, Chi2Gel Ltd., Chi2Knee, Cocoon Biotech, Inc., Silk Hydrogel, Flex Biomedical, Inc., Flex Polymer, Moebius Medical Ltd., MM-II, OrthogenRx Inc., OrthogenRx Device, Synolyne Pharma, Arthrovisc, University of Kansas, 3-D Colloidal Gel


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com